Janice Cowden, Former nurse, Cancer patient and Advocate, posted on LinkedIn:
“Help the Patient-Centered Dosing Initiative answer questions about dosing and side effects with Trodelvy, Enhertu, Kadcyla and antibody-drug conjugates (ADCs) in clinical trial. If you live in the US, have been on one of these drugs and have Metastatic Breast Cancer, we need to hear from you. The research survey takes about 20 minutes, and we hope will lead to better understanding and improve future treatment experience. The results from this survey will be posted at following presentation/publication.
E-mail [email protected] for a survey link!
If you have questions about the survey, please reach out to [email protected].”
